Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.
Merck & Co., Inc. (NYSE:MRK)’s Financial Overview
Merck & Co., Inc. (NYSE:MRK) surged 0.63% yesterday to close its trading session at $62.19. The company has 1 year Price Target of $68.32. Merck & Co., Inc. has 52-Week high of $65.46 and 52-Week Low of $47.97. The stock touched its 52-Week High on Nov 10, 2016 and 52-Week Low on Feb 8, 2016. The stock traded with the volume of 9.29 Million shares yesterday. The firm shows the market capitalization of $171.47 Billion.
Merck & Co., Inc. (NYSE:MRK) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $1.07/share against the analyst consensus estimate of $0.99/share. The difference between the actual and expected EPS is $0.08 a share with a surprise factor of 8.1%.
The firm is trading with SMA20 of 0.98 Percent, SMA50 of 0.51 Percent and SMA200 of 7.98 percent. Merck & Co., Inc. has P/S value of 4.3 while its P/B value stands at 3.93. Similarly, the company has Return on Assets of 5.6 percent, Return on Equity of 12.5 percent and Return on Investment of 6.4 Percent. The company shows Gross Margin and Operating Margin of 64.5 percent and 19.6 percent respectively.
Many brokerage firms are involved in issuing their ratings on Merck & Co., Inc. (NYSE:MRK). On 13-Oct-16 BofA/Merrill Upgrade Merck & Co., Inc. Stock to Buy. Another firm also rated the stock on 8-Aug-16 where Credit Suisse Upgrade the stock to Outperform.
The Stock currently has Analyst’ mean Recommendation of 2.4 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 21 analysts offering 12-month price forecasts for Merck have a median target of 68.00, with a high estimate of 82.00 and a low estimate of 59.00. The median estimate represents a +9.34% increase from the last price of 62.19.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM)
Taiwan Semiconductor Manufacturer Co is the world’s largest dedicated integrated circuit foundry. As a foundry, the Company manufactures ICs for its customers based on their proprietary IC designs using its advanced production processes. TSMC’s goal is to establish itself as one of the world’s leading semiconductor companies by building upon the strengths that have made it the leading IC foundry in the world.
Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM)’s Financial Outlook
The 27 analysts offering 12-month price forecasts for Taiwan Semiconductor have a median target of 32.74, with a high estimate of 36.40 and a low estimate of 24.24. The median estimate represents a +10.80% increase from the last price of 29.55.
Taiwan Semiconductor Manufacturing Company Ltd. is estimated to report earnings on 01/12/2017. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.58. The reported EPS for the same quarter last year was $0.43.
According to Zacks Investment Research, Taiwan Semiconductor Manufacturing Company Limited has a Consensus Recommendation of 2.33. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock fell -0.37% and closed its last trading session at $29.55. The company has the market capitalization of $149.72 Billion. The stock has 52-week high of $31.62 and 52-Week low of $20.45. The firm touched its 52-Week high on Oct 25, 2016 and 52-Week low on Jan 13, 2016. The company has volume of 9.25 Million shares. The company has a total of 5.07 Billion shares outstanding.
Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) in the last quarter reported its actual EPS of $0.59/share where the analyst estimated EPS was $0.57/share. The difference between the actual and Estimated EPS is $0.02. This shows a surprise factor of 3.5 percent.
The company has YTD performance of 34.77 percent. Beta for Taiwan Semiconductor Manufacturing Company Limited stands at 0.92 while its ATR (average true range) is 0.56. The company has Weekly Volatility of 1.34%% and Monthly Volatility of 1.96%%.
Taiwan Semiconductor Manufacturing Company Limited has distance from 20-day Simple Moving Average (SMA20) of -1.66%, Distance from 50-Day Simple Moving Average of -2.93 percent and Distance from 200-Day Simple Moving Average of 10.31%.
The Company currently has ROA (Return on Assets) of 17.8 percent, Return on Equity (ROE) of 24.6 Percent and Return on Investment (ROI) of 18.7% with Gross margin of 49.1 percent and Operating & Profit margin of 38.9% and 34.5% respectively.